Importer of Controlled Substances Application: Rhodes Technologies, 22070 [2021-08539]
Download as PDF
<![CDATA[
22070
Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: April 21, 2021.
Lisa Barton,
Secretary to the Commission.
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 15, 2021,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Tetrahydrocannabinols ..........
Methylphenidate .....................
Oxycodone .............................
Hydromorphone .....................
Hydrocodone ..........................
Morphine ................................
Opium, Raw ...........................
Oxymorphone ........................
Poppy Straw Concentrate ......
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–827]
Importer of Controlled Substances
Application: Rhodes Technologies
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice of application.
AGENCY:
Rhodes Technologies has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
SUMMARY:
2 All
contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
18:01 Apr 23, 2021
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
Controlled substance
[FR Doc. 2021–08654 Filed 4–23–21; 8:45 am]
VerDate Sep<11>2014
issuance of the proposed registration on
or before May 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 26, 2021.
Jkt 253001
Schedule
7370
1724
9143
9150
9193
9300
9600
9652
9670
I
II
II
II
II
II
II
II
II
The company plans to import Opium,
Raw (9600), and Poppy Straw
Concentrate (9670) in order to bulk
manufacture controlled substances in
Active Pharmaceutical Ingredient (API)
form. The company distributes the
manufactured APIs in bulk to its
customers.
The company plans to import the
other listed controlled substances for
internal reference standards use only.
The comparisons of foreign reference
standards to the company’s
domestically manufactured API will
allow the company to export
domestically manufactured API to
foreign markets.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–08539 Filed 4–23–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–NEW]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; New Proposed
Collection Exempt Chemical
Preparations Application
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until June
25, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott A. Brinks, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (571) 362–3261.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
SUMMARY:
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 86, Number 78 (Monday, April 26, 2021)]
[Notices]
[Page 22070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08539]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-827]
Importer of Controlled Substances Application: Rhodes
Technologies
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Rhodes Technologies has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 26, 2021.
Such persons may also file a written request for a hearing on the
application on or before May 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 15, 2021, Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
Methylphenidate........................ 1724 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Morphine............................... 9300 II
Opium, Raw............................. 9600 II
Oxymorphone............................ 9652 II
Poppy Straw Concentrate................ 9670 II
------------------------------------------------------------------------
The company plans to import Opium, Raw (9600), and Poppy Straw
Concentrate (9670) in order to bulk manufacture controlled substances
in Active Pharmaceutical Ingredient (API) form. The company distributes
the manufactured APIs in bulk to its customers.
The company plans to import the other listed controlled substances
for internal reference standards use only. The comparisons of foreign
reference standards to the company's domestically manufactured API will
allow the company to export domestically manufactured API to foreign
markets.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08539 Filed 4-23-21; 8:45 am]
BILLING CODE 4410-09-P
